CHEST 2023 On Demand Pass-Pneumotoxicity: What You Need to Know About Medications and Lung Injury

Pneumotoxicity: What You Need to Know About Medications and Lung Injury

Video Transcription

Video Summary

The video discusses pneumotoxicity, specifically the effects of medications on lung injury. The speaker begins by giving an overview of the session, which includes presentations on medication-induced pulmonary vascular disease and balancing the risks and benefits of medications with potential toxicity. The speaker emphasizes the importance of considering drugs as a possible cause of lung disease, thinking about risk factors such as smoking history, previous lung diseases, and certain medications. They stress the need for a detailed patient history and careful assessment of the temporal relationship between medication use and the onset of symptoms. The speaker presents several case examples to illustrate the challenges of managing drug-induced lung injury, including considerations for continuing or discontinuing medication and potential alternative therapies. The video highlights the role of a multidisciplinary approach involving oncologists, pulmonologists, and the patient in making treatment decisions. The speaker concludes by emphasizing the need for ongoing monitoring and close follow-up of patients with drug-induced lung injury.

Meta Tag

Category Diffuse Lung Disease

Session ID 2020

Speaker Peter Leary

Speaker Andrew Limper

Speaker Namita Sood

Track Diffuse Lung Disease

Track Pulmonary Vascular Disease

Keywords

pneumotoxicity

medications

lung injury

risk factors

patient history

case examples

alternative therapies

multidisciplinary approach

follow-up